Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10662/20211
Registro completo de Metadatos
Campo DCValoridioma
dc.contributor.authorPerkins, James R.-
dc.contributor.authorAyuso Parejo, Pedro-
dc.contributor.authorCornejo García, José Antonio-
dc.contributor.authorRanea, Juan A-
dc.date.accessioned2024-02-07T10:30:20Z-
dc.date.available2024-02-07T10:30:20Z-
dc.date.issued2014-08-
dc.identifier.issn1528-4050-
dc.identifier.issn1473-6322-
dc.identifier.urihttp://hdl.handle.net/10662/20211-
dc.description.abstractPurpose of review Stevens–Johnson syndrome and toxic epidermal necrolysis are severe hypersensitivity reactions, the majority of which are drug induced. The underlying mechanisms are not fully understood. Here, we review recent findings concerning both mechanistic and genetic factors related to these diseases and propose future approaches to unravel their complexity. Recent findings Genome-wide association study studies have identified several variants in the human leukocyte antigen region associated with these reactions. These are highly dependent on the population studied and the triggering drug. The T-cell receptor repertoire of the patient is also key. Fas–Fas ligand interactions, perforin and granulysin have also been identified as important players. Furthermore, a high-throughput gene expression study has identified a number of genes that increase in expression in patients during the acute phase of these reactions. Summary We review recent high-throughput studies on these diseases and suggest ways in which the data can be combined and reanalyzed using integrative systems biology techniques. We also suggest future lines of research using recent technology that could shed further light on their underlying mechanisms. Keywords human leukocyte antigen, hypersensitivity drug reactions, Stevens–Johnson syndrome, systems biology, T cells, toxic epidermal necrolysises_ES
dc.format.extent6es_ES
dc.format.mimetypeapplication/pdfen_US
dc.language.isoenges_ES
dc.publisherLippincott Williams & Wilkinses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectBiología de sistemas, síndrome Steven-Johnson, células Tes_ES
dc.subjectSystems Biology, Steven-Johnson syndrome, T cellses_ES
dc.titleThe study of severe cutaneous drug hypersensitivity reactions from a systems biology perspectivees_ES
dc.typearticlees_ES
dc.description.versionpeerReviewedes_ES
europeana.typeTEXTen_US
dc.rights.accessRightsopenAccesses_ES
dc.subject.unesco3209 Farmacologíaes_ES
dc.subject.unesco3207.01 Alergiases_ES
europeana.dataProviderUniversidad de Extremadura. Españaes_ES
dc.type.versionpublishedVersiones_ES
dc.contributor.affiliationUniversidad de Extremadura. Departamento de Terapéutica Médico-Quirúrgicaes_ES
dc.relation.publisherversion10.1097/ACI.0000000000000076es_ES
dc.identifier.publicationtitleCurrent Opiniones_ES
dc.identifier.publicationissue14es_ES
dc.identifier.publicationfirstpage301es_ES
dc.identifier.publicationlastpage306es_ES
dc.identifier.orcid0000-0002-9441-4022es_ES
Colección:DTMQU - Artículos

Archivos
Archivo Descripción TamañoFormato 
ACI_0000000000000076.pdf142,64 kBAdobe PDFDescargar


Este elemento está sujeto a una licencia Licencia Creative Commons Creative Commons